Northwick Park Hospital Drug Trial
![Bbc News Health Drug Trial Man May Lose Fingers](https://www.leighday.co.uk/getmedia/f32ac3e3-a725-4715-a18d-d1c0ea4a237a/Vaccine.aspx?width=612&height=407&ext=.jpg)
I had been involved in more than 300 trials by march 2006 when i was put in charge of testing a new drug in the private wing of northwick park hospital in north london.
Northwick park hospital drug trial. One of the men is still recovering in hospital. The novel drug called tgn1412 caused multiple organ failure in the six men who were injected with it at northwick park hospital london uk. The men aged 19 to 34 were each paid 2 000 to be given the drug. The phase i clinical trials were conducted by parexel at an independent clinical trials unit in leased space on the premises of northwick park and st.
This is the initial phase in assessing the. The trial which was privately run at a research facility at northwick park hospital in north london involved the first testing of a new drug on humans. This is the initial phase in assessing the. Bloomberg via getty images the trial took place at an independent clinic at northwick park hospital pictured within an hour of receiving the drug six of the volunteers had been rushed to.
When rob oldfield signed up for a drugs trial at northwick park hospital in 2006 he thought he had found a way to earn some easy money and do his bit for medical science. Nav then 24 and five other volunteers were left fighting for life following the trial at northwick park hospital in london in march 2006. Mark s hospital london on 13 march 2006. But the trial went.
The trial which was privately run at a research facility at northwick park hospital in north london involved the first testing of a new drug on humans. In march 2006 six healthy men all under the age of 40 signed up as volunteers in a drug trial that was being conducted at a research unit based at northwick park hospital in northwest london. The drug being tested was tgn1412 an anti inflammatory drug designed to treat conditions such as leukaemia rheumatoid arthritis and multiple sclerosis.